Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	17.13	-100.27	-120.99
Graham Fair Price	-35.85	3.70	5.77
PEG	4586.02	0.40	< 0.005
Price/Book	-13.82	0.87	1.01
Price/Cash Flow	-73.34	-14.19	53.23
Prices/Earnings	-108.27	-22.93	-11.01
Price/Sales	-15.02	5.81	6.83
Price/FCF	-73.34	-14.19	53.23
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-46.41	0.01	-0.02
Operating Margin	61.14	-0.07	-0.19
ROA	58.70	< 0.005	-0.02
ROE	-0.02	< 0.005	58.62
ROIC	-0.02	< 0.005	58.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.18	0.05	259.65
Dividends QOQ	0.74	-0.12	-83.25
EBIT QOQ	-16.09	0.61	-96.21
EPS QOQ	-13.00	0.58	-95.56
FCF QOQ	0.85	-4.20	396.72
Revenue QOQ	0.02	< 0.005	-72.19
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	134.36	147.35	9.67
Days Sales Outstanding (DSO)	146.26	157.30	7.54
Inventory Turnover	0.67	0.61	-8.82
Debt/Capitalization	0.10	0.12	16.56
Quick Ratio	0.82	0.78	-4.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.04	8.02	-0.28
Cash	0.80	0.45	-44.10
Capex	0.23	-0.18	-22.12
Free Cash Flow	0.15	-0.49	222.42
Revenue	1.19	1.20	1.13
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.39	1.40	1.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.06	-7.73	-632.48
Naive Interpretation	Member

06 - Financial Health · Weak

Rating